Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04125719
Title PVSRIPO in Combination With Nivolumab in Melanoma (PPD1)
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Darell D. Bigner, MD, PhD
Indications

melanoma

Therapies

Nivolumab + PVSRIPO

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.